Atmika Paul, Postdoctoral Researcher at Universitätsmedizin Göttingen, shared on LinkedIn:
“Thought p53 was the only guardian of our genome? Meet another: SMAD4.
Excited to share that our work from Universitätsmedizin Göttingen is finally published in Science Advances!
We uncover a previously unrecognized role for SMAD4 in safeguarding genome integrity, revealing how its loss drives both structural and numerical chromosomal instability (CIN) in human cancers.
- When transcription clashes with replication: SMAD4 loss promotes head-on collisions between transcription and replication machineries (TRCs), triggering replication stress.
- Beyond TGF-β: Unexpectedly, the genome-protective function of SMAD4 relies on BMP–SMAD4 signaling, a pathway better known for its roles in early development.
- The key effector, ID3: SMAD4 loss downregulates ID3, a transcriptional target of BMP–SMAD4 signaling. This impedes RAD51 recruitment at DNA damage sites, thus impairing homologous recombination (HR).
- From replication stress to CIN: Together, defective DNA repair and replication stress lead to chromosome breaks and mitotic segregation errors, driving persistent structural chromosomal aberrations and aneuploidy in cancers.
- A therapeutic vulnerability: Loss of SMAD4 creates HR deficiency and this sensitizes cancer cells to platinum-based therapies in our experimental models.
With SMAD4 expression lost in approximately 60% of pancreatic cancers and 20% of colorectal cancers, our findings reveal a previously underappreciated route to chromosomal instability and highlight the importance of uncovering new regulators of genome integrity.
Grateful to our wonderful collaborators and coauthors who made this work possible!”
Title: SMAD4 loss drives cancer chromosomal instability through transcription-replication conflict–associated replication stress
Authors: Atmika Paul, Gargee Joshi, Philipp Jungk, Simranjeet Kaur, Shengyu Yao, Ioannis Tsirkas, Nicolas Böhly, Maren Sitte, Gabriela Salinas, Stephan Hamperl, Maik Kschischo, Holger Bastians.
You can also read:
Joshua Schiffman: Translating Elephant p53’s Cancer-Fighting Biology Into Potential New Treatments